All News

Al Carter of the National Association of Boards of Pharmacy speaks on recent initiatives to address workforce burnout and stress among pharmacists.

Promoting antimicrobial stewardship and providing patient education are examples of strategies to prevent antimicrobial resistance.

The tumor-agnostic FDA approval of T-DXd for HER2-positive unresectable or metastatic solid malignancies exemplifies the importance of understanding the risks associated with targeted therapy and the need for proactive monitoring strategies.

As use of injectable medications increases for diabetes and other indications, proper administration is crucial.

AI-powered drug response prediction technology is revolutionizing veterinary and human oncology by enabling personalized treatment plans through live cell testing, machine learning models, and data-driven precision medicine approaches.

AI-enabled remote cardiac telemetry can help manage stress’s effects on high-risk populations.

The pharmacist’s role includes determining if there are any medications that are contributing to magnesium deficiency for patients with diabetes who are at an increased risk.

Investigators presented additional data from a clinical trial at the American College of Rheumatology Convergence, demonstrating similar safety for postmenopausal women with osteoporosis.

The Act is set to end at the end of 2024, which will affect pharmacists’ abilities to administer COVID-19 tests, vaccines, and treatment that are distributed by the federal government.

Lipoprotein(a) is a known risk factor for atherosclerotic cardiovascular disease.

Asthma onset earlier in childhood may be linked to more severe difficulties that could extend to executive function abilities.

Anemia is a common adverse effect of ruxolitinib, calling for new approaches to mitigate risks.

The biosimilar is approved for the treatment of Crohn disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis.

Treatment for RLS includes lifestyle modifications, medication, and in some cases, non-drug therapies, aiming to reduce symptoms and improve sleep and daytime functioning.

Potential solutions can include international funding, improved primary health care measures, and cost-effective screening methods.

The addition of navitoclax was associated with durable response and potential disease modification.

The combined effects of cagrilintide and semaglutide in CagriSema offer a dual approach to weight loss and glucose regulation.

Pneumococcal disease incidence decreased in adults after pneumococcal vaccines began to be used in children due to indirect protection, with fewer adults found to carry the bacterium that causes disease.

Rick C. McCoy, RPh, and Marge McCoy, RPh, combine decades of experience working side by side with a dedication to serving their island community.

Legislative efforts regarding cybersecurity are ongoing, but individuals and organizations should remain vigilant.

Rising health care costs and the complex nature of medication management have prompted PBMs to adopt AI tools to enhance patient outcomes, streamline claims processes, reduce waste, and design smarter, data-driven health plans.

Researchers developed a method to stabilize respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) fusion (F) proteins, advancing potential vaccines for both viruses.

Knowledge of recent intravenous immunoglobulin (IVIG) administration in patients receiving the common laboratory test can help inform misdiagnosis.

Using multiple physicians or pharmacists can result in a lack of coordinated care, missed medication interactions, and overlooked contraindications.

Tryptophan, found in turkey and other foods, affects serotonin and melatonin production.

Evidence suggests that precautionary measures in elementary schools were able to effectively mitigate large increases in disease transmission.

In trials, blood pressure reductions were maintained over extended periods, suggesting that the drug could offer a sustained effect.

These findings are significant in understanding interactions between glucagon-like peptide-1 medications and thyroid dysfunction because prior research has shown conflicting results.